http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101348550-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385 |
filingDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101348550-B1 |
titleOfInvention | Pharmaceutical composition for treating thyroid cancer containing any one or more compounds selected from α-lipoic acid or derivatives thereof as an active ingredient |
abstract | The present invention relates to a pharmaceutical composition for treating thyroid cancer and health foods containing any one or two or more compounds selected from α-lipoic acid or derivatives thereof, and α-lipoic acid or its active form dihydrolipoic acid is a thyroid-specific gene. For example, it can be used as a novel differentiation inducer of thyroid cancer by promoting the expression of sodium iodine transporter (NIS), thyroid globulin (Tg) or thyroid transcription factor-1 (TTF-1).n n n n α-lipoic acid, thyroid cancer, sodium iodine transporter, thyroid globulin, thyroid transcription factor-1, differentiation inducer, dihydrolipoic acid |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200031219-A |
priorityDate | 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.